tiprankstipranks
Tetra Bio-Pharma Inc (TSE:TBP)
TSX:TBP
Canadian Market

Tetra Bio-Pharma (TBP) Financial Statements

81 Followers

Tetra Bio-Pharma Financial Overview

Tetra Bio-Pharma's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Tetra Bio-Pharma is scheduled to report earnings on April 1, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 22May 22Feb 22Nov 21Aug 21
Income Statement-
Total Revenue--C$ 0.00C$ 0.00C$ 0.00
Gross Profit-----
EBITC$ -3.39MC$ -3.61MC$ -1.49MC$ -28.88MC$ -5.87M
EBITDAC$ -3.37MC$ -3.58MC$ -1.46MC$ -28.84MC$ -5.84M
Net Income Common StockholdersC$ -3.49MC$ -3.72MC$ -1.63MC$ -30.19MC$ -5.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 483.20KC$ 1.74MC$ 3.67MC$ 4.89MC$ 8.57M
Total AssetsC$ 3.02MC$ 4.93MC$ 8.80MC$ 7.55MC$ 36.99M
Total DebtC$ 1.66MC$ 2.15MC$ 2.65MC$ 3.11MC$ 3.00M
Net DebtC$ 1.18MC$ 414.80KC$ -1.02MC$ -1.77MC$ -5.57M
Total LiabilitiesC$ 8.93MC$ 7.51MC$ 8.27MC$ 7.30MC$ 6.37M
Stockholders EquityC$ -5.91MC$ -2.59MC$ 526.98KC$ 249.33KC$ 30.62M
Cash Flow-
Free Cash FlowC$ -873.53KC$ -1.92MC$ -2.39MC$ -3.03MC$ -7.69M
Operating Cash FlowC$ -873.53KC$ -1.92MC$ -2.39MC$ -3.00MC$ -7.55M
Investing Cash Flow--C$ 0.00C$ -683.75KC$ -139.51K
Financing Cash FlowC$ -378.47KC$ -18.18KC$ 1.18MC$ 0.00C$ 26.73K
Currency in CAD

Tetra Bio-Pharma Earnings and Revenue History

Tetra Bio-Pharma Debt to Assets

Tetra Bio-Pharma Cash Flow

Tetra Bio-Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis